A Study of Pazopanib Safety and Efficacy in Patients With Advanced Clear Cell Renal Cell Carcinoma and ECOG Performance Status 2 (Pazo2): An Open label, Multicentre, Single Arm, Phase II Trial
- Resource Type
- Article
- Source
- In
Clinical Genitourinary Cancer October 2022 20(5):473-481 - Subject
- Language
- ISSN
- 1558-7673